Market Access News | pharmaphorum

News

Sanofi steps in to boost supplies of Pfizer/BioNTech's COVID...

Sanofi has said it is to begin manufacturing the COVID-19 shot from Pfizer and BioNTech in a week when supplies are in the spotlight.

News

EU eyes tighter COVID-19 vaccine exports as access gets ugly

The EU has hit back at AstraZeneca’s plan to provide fewer doses of its COVID-19 vaccine than expected, saying it wants to see exactly where supplies have been delivered so far.

News

ViiV/J&J's long-acting HIV regimen finally approved in US

The FDA has approved Cabenuva, a long-acting HIV treatment from ViiV and Johnson & Johnson that keeps the virus at bay with a monthly injection instead of daily pill regimen.

Market Access

NICE rejects BMS' Zeposia MS pill in provisional guidance

NICE has said that the NHS should not fund Bristol-Myers Squibb’s multiple sclerosis pill Zeposia (ozanimod) for relapsing multiple sclerosis in first draft guidance.

News

Vaccine vial dose flu shot drug needle syringe,medical concept vaccination hypodermic injection treatment disease care hospital prevention immunization illness disease baby child.blue background

Russia asks for "non-political" treatment of Sputnik V shot,...

The state-owned backers of Russia’s Sputnik V coronavirus vaccine have ruled out a US filing, as talks began in earnest with European regulators over a review.

News

NICE backs broad use for Gilead/Galapagos arthritis pill Jys...

Patients with rheumatoid arthritis (RA) in England will be able to get treatment with Gilead Sciences and Galapagos’ JAK inhibitor Jyseleca, after it was backed by cost-effectiveness agency

Sanofi steps in to boost supplies of Pfizer/BioNTech's COVID...

EU eyes tighter COVID-19 vaccine exports as access gets ugly

ViiV/J&J's long-acting HIV regimen finally approved in US

NICE rejects BMS' Zeposia MS pill in provisional guidance

Russia asks for "non-political" treatment of Sputnik V shot,...

NICE backs broad use for Gilead/Galapagos arthritis pill Jys...

Google Cloud launches Gemini for Healthcare

Securing your ROI: Turning post-acquisition integration into...

News

Editor's Picks